Literature DB >> 12933353

Intravenous angiotensin induces brain c-fos expression and vasopressin release in the near-term ovine fetus.

Lijun Shi1, Fang Hu, Paul Morrissey, Jiaming Yao, Zhice Xu.   

Abstract

The effect of intravenous angiotensin II (ANG II) on fetal brain c-fos expression and arginine vasopressin (AVP) release was studied in the near-term ovine fetus. Fetuses with chronically implanted catheters received an intravenous infusion of ANG II or saline. Fetal plasma AVP concentrations were significantly increased after the peripheral administration of ANG II, with peak levels (3-fold) at 30 min after the intravenous infusion. There was no change in fetal plasma osmolality, sodium, and hematocrit levels between the control and experimental groups or between the periods before and after the infusion of ANG II. Intravenous ANG II administration induced Fos immunoreactivity (Fos-IR) in the circumventricular organs and the median preoptic nucleus of the fetal brain. Fos-IR was also demonstrated in the fetal supraoptic nuclei (SON). Double labeling demonstrated that the AVP-containing neurons in the SON were expressing c-fos in response to intravenous ANG II. These results indicate that the peripheral ANG II in the fetus may play a significant role in stimulating the central hypothalamic-neurohypophysial system during late gestation. It supports the hypothesis that circulating ANG II may act at the fetal AVP neurons in the hypothalamus in body fluid balance via the circumventricular organs, which are situated outside the blood-brain barrier, and the central neural pathway between these two brain structures has been relatively established in utero, at least at near-term.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933353     DOI: 10.1152/ajpendo.00289.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  AT1a receptor signaling is required for basal and water deprivation-induced urine concentration in AT1a receptor-deficient mice.

Authors:  Xiao C Li; Yuan Shao; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2012-06-27

2.  Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.

Authors:  Juan Gao; Jie Chao; Karma-Jaya K Parbhu; Li Yu; Liang Xiao; Fei Gao; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-04-22       Impact factor: 1.636

3.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

4.  Changes of renal AT1/AT2 receptors and structures in ovine fetuses following exposure to long-term hypoxia.

Authors:  Caiping Mao; Jianquan Hou; Jianyi Ge; Yali Hu; Yang Ding; Yun Zhou; Huiying Zhang; Zhice Xu; Lubo Zhang
Journal:  Am J Nephrol       Date:  2009-11-18       Impact factor: 3.754

Review 5.  Development of fetal brain renin-angiotensin system and hypertension programmed in fetal origins.

Authors:  Caiping Mao; Lijun Shi; Feichao Xu; Lubo Zhang; Zhice Xu
Journal:  Prog Neurobiol       Date:  2009-01-24       Impact factor: 11.685

6.  AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice.

Authors:  Yongjun Zhu; Hongwang Cui; Jie Lv; Haiqin Liang; Yanping Zheng; Shanzhi Wang; Min Wang; Huanan Wang; Feng Ye
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.